-
Mashup Score: 0
NatureMills US Inc., based in Prosper, Texas, is recalling select products that were sold between December 1, 2023, and May 10, 2025, due to undeclared allergens: Wheat, Milk, and Sesame. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 0
HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 0Ariana Sweets Inc. Issues Allergy Alert on Undeclared Sesame and Wheat in AFGHANI CORN BREAD (“Doda”) - 1 day(s) ago
May, 13, 2025, Ariana Sweets Inc. of Fremont, CA is recalling AFGHANI CORN BREAD “Doda” manufactured prior to 4/24/2025, because it may contain undeclared sesame and wheat. People who have an allergy or severe sensitivity to sesame or wheat run the risk of serious or life-threatening allergic react
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 15
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 15
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 60
On May 14, 2025, the Food and Drug Administration granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis, AbbVie Inc.)
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 14
On May 14, 2025, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients 12 years and older
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 60
On May 14, 2025, the Food and Drug Administration granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis, AbbVie Inc.)
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 14
On May 14, 2025, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients 12 years and older
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 2What are product recalls and why are they important - 3 day(s) ago
What you need to know about product recalls and how the FDA helps protect the public from potentially dangerous products.
Source: www.fda.govCategories: General Medicine NewsTweet
NatureMills US Inc. Issues Allergy Alert on Undeclared Wheat, Milk, and Sesame in Rice Mixes, Soups, Spice Mixes, Porridge Mix, Papads and Vadam Products https://t.co/N67tHY3Opa